Aura Biosciences, Inc.
AURA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001501796
No open-market purchases or sales by Aura Biosciences, Inc. insiders were filed in the last 90 days; 146 institutions reported holding it in 13F filings for Q2 2026, worth $677.2M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Aura Biosciences, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 44
- +11 vs. Q1 2022
- Shares held
- 15.8M
- +2.09M (+15.3%) vs. Q1 2022
- Total value
- $223.8M
- −$74.9M (−25.1%) vs. Q1 2022
- New holders
- 11
- 24 more added
- Sold out
- 0
- 5 more reduced
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AURA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 146 | $677.2M |
| Q1 2026 | 126 | $340.3M |
| Q4 2025 | 117 | $273.8M |
| Q3 2025 | 106 | $319.2M |
| Q2 2025 | 105 | $316.9M |
| Q1 2025 | 94 | $231.5M |
| Q4 2024 | 94 | $324.3M |
| Q3 2024 | 81 | $329.2M |
| Q2 2024 | 75 | $300.4M |
| Q1 2024 | 78 | $307.1M |
| Q4 2023 | 72 | $327.8M |
| Q3 2023 | 64 | $254.4M |
| Q2 2023 | 59 | $334.4M |
| Q1 2023 | 57 | $232.6M |
| Q4 2022 | 49 | $250.0M |
| Q3 2022 | 43 | $295.7M |
| Q2 2022 | 44 | $223.8M |
| Q1 2022 | 34 | $298.8M |
| Q4 2021 | 32 | $220.1M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Aura Biosciences, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Credit Suisse AG | 12 | $0 | 0.00% | +12 | New |
| Royal Bank of Canada | 103 | $1.00K | 0.00% | −242−70.1% | Reduced |
| Wells Fargo & Company | 430 | $6.00K | 0.00% | −791−64.8% | Reduced |
| Clear Street Markets LLC | 750 | $11.0K | 0.00% | +750 | New |
| Legal & General Group Plc | 862 | $12.0K | 0.00% | +360+71.7% | Added |
| STRS Ohio | 1,300 | $18.0K | 0.00% | 00.0% | Unchanged |
| Metropolitan Life Insurance Co | 1,280 | $18.1K | 0.00% | +1,280 | New |
| Ameritas Investment Partners, Inc. | 1,374 | $19.0K | 0.00% | +953+226.4% | Added |
| Amalgamated Bank | 2,896 | $41.0K | 0.00% | +2,105+266.1% | Added |
| Tower Research Capital LLC (TRC) | 3,949 | $56.0K | 0.00% | +2,840+256.1% | Added |
| California State Teachers Retirement System | 7,836 | $111.0K | 0.00% | +5,478+232.3% | Added |
| American International Group, Inc. | 8,577 | $122.0K | 0.00% | +5,795+208.3% | Added |
| Deutsche Bank AG | 9,261 | $131.0K | 0.00% | +6,311+213.9% | Added |
| JPMorgan Chase & Co | 9,798 | $139.0K | 0.00% | +7,170+272.8% | Added |
| MetLife Investment Management | 11,026 | $156.2K | 0.00% | +11,026 | New |
| Captrust Financial Advisors | 13,414 | $190.0K | 0.00% | +13,414 | New |
| New York State Common Retirement Fund | 14,352 | $203.0K | 0.00% | +8,100+129.6% | Added |
| Water Island Capital LLC | 14,541 | $206.0K | 0.01% | +14,541 | New |
| UBS Group AG | 16,320 | $231.0K | 0.00% | +15,566+2,064.5% | Added |
| Rhumbline Advisers | 20,713 | $294.0K | 0.00% | +20,713 | New |
| Millennium Management LLC | 22,917 | $325.0K | 0.00% | +22,917 | New |
| Bank of America Corp | 35,343 | $501.0K | 0.00% | +23,486+198.1% | Added |
| Bank of New York Mellon Corp | 40,096 | $569.0K | 0.00% | +25,600+176.6% | Added |
| Barclays PLC | 42,186 | $598.0K | 0.00% | −17,511−29.3% | Reduced |
| Charles Schwab Investment Management Inc | 43,009 | $610.0K | 0.00% | +27,630+179.7% | Added |
| Morgan Stanley | 54,539 | $772.0K | 0.00% | +53,430+4,817.9% | Added |
| Nuveen Asset Management, LLC | 61,227 | $868.0K | 0.00% | +61,227 | New |
| Allianz Asset Management GmbH | 61,575 | $873.0K | 0.00% | +6,430+11.7% | Added |
| UBS Oconnor LLC | 90,539 | $1.28M | 0.01% | +90,539 | New |
| Citigroup Inc | 123,188 | $1.75M | 0.00% | +122,969+56,150.2% | Added |
| Northern Trust Corp | 132,692 | $1.88M | 0.00% | +86,621+188.0% | Added |
| Geode Capital Management, LLC | 207,294 | $2.94M | 0.00% | +101,960+96.8% | Added |
| Decheng Capital Management III (Cayman), LLC | 210,000 | $2.98M | 1.13% | 00.0% | Unchanged |
| Regency Capital Management Inc. | 254,622 | $3.61M | 3.88% | +254,622 | New |
| State Street Corp | 256,746 | $3.64M | 0.00% | +171,764+202.1% | Added |
| Nantahala Capital Management, LLC | 343,215 | $4.86M | 0.42% | +41,225+13.7% | Added |
| Vanguard Group Inc | 435,175 | $6.17M | 0.00% | +206,542+90.3% | Added |
| FMR LLC | 603,471 | $8.55M | 0.00% | +109,362+22.1% | Added |
| BlackRock Inc. | 886,723 | $12.6M | 0.00% | +611,696+222.4% | Added |
| Rock Springs Capital Management LP | 1,008,814 | $14.3M | 0.42% | +700+0.1% | Added |
| Adage Capital Partners GP, L.L.C. | 1,276,619 | $18.1M | 0.04% | −20,400−1.6% | Reduced |
| Citadel Advisors LLC | 2,312,159 | $32.8M | 0.04% | −4,494−0.2% | Reduced |
| Medicxi Ventures Management (Jersey) Ltd | 3,039,892 | $43.1M | 17.89% | 00.0% | Unchanged |
| Matrix Capital Management Company, LP | 4,112,870 | $58.3M | 1.32% | 00.0% | Unchanged |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |